Podcast
What BioPlan’s 22-Year Data Reveals About the Future of Biopharmaceutical Outsourcing
“If you can’t demonstrate international quality standards, nobody is going to take a chance on a million-dollar batch to save a few dollars on their manufacturing. It just won’t happen.” Eric Langer is President of BioPlan Associates, where he has
1 December 2025
